Management of acute renal replacement therapy in critically ill cirrhotic patients

• Published in: Clinical kidney journal 2022-06, Vol.15 (6), p.1060-1070
• Main Authors: Del Risco-Zevallos, Jimena, Andújar, Alicia Molina, Piñeiro, Gastón, Reverter, Enric, Toapanta, Néstor David, Sanz, Miquel, Blasco, Miquel, Fernández, Javier, Poch, Esteban
• Format: Article
• Language: English
• Subjects: Albumin; Blood; Care and treatment; CKJ Review; Epidemiology; Health aspects; Hospital patients; Liver cirrhosis; Medical examination; Mortality; Prognosis
• ISSN: 2048-8505; 2048-8513
• DOI: 10.1093/ckj/sfac025

ABSTRACT Renal replacement therapy (RRT) in cirrhotic patients encompasses a number of issues related to the particular characteristics of this population, especially in the intensive care unit (ICU) setting. The short-term prognosis of cirrhotic patients with acute kidney injury is poor, with a mortality rate higher than 65% in patients with RRT requirement, raising questions about the futility of its initiation. Regarding the management of the RRT itself, there is still no consensus with respect to the modality (continuous versus intermittent) or the anticoagulation required to improve the circuit life, which is shorter than similar at-risk populations, despite the altered haemostasis in traditional coagulation tests frequently found in these patients. Furthermore, volume management is one of the most complex issues in this cohort, where tools used for ambulatory dialysis have not yet been successfully reproducible in the ICU setting. This review attempts to shed light on the management of acute RRT in the critically ill cirrhotic population based on the current evidence and the newly available tools. We will discuss the timing of RRT initiation and cessation, the modality, anticoagulation and fluid management, as well as the outcomes of the RRT in this population, and provide a brief review of the albumin extracorporeal dialysis from the point of view of a nephrologist.